Search

News and updates

Posted in Press releases, Advocacy news, Stakeholder news and views, Meeting reports, Tutorial reports, EHA's actions for Ukraine, IVDR, Health Data, member news, EU HTA Tagged personalized medicine, membership, membership renewal, Ulrich Jäger, pricing issue, EHA position on, drug pricing, EHA position on drug pricing, EHA tutorial, thalassemia, leukemia, acute leukemia, plasma cell disorders, lymphoproliferative and plasma cell disorders, precision medicine, CAR T, EBMT, Immunotherapy, Topics-in-Focus, CMML, Guidelines, HemaSphere, European Hematology Association, European LeukemiaNet, EHA, obituary, Boiron, health technology assessment, regulation, joint actions, EU Health Program, legislation, advocacy news, Stakeholder news & views’, SCD, Registry, early detection, report, EHA24, EHA congress, hemAffairs, european parliament, MEP, harmonization, CTR, funding, cancer, ATMP, IMI2, Horizon 2020, bureaucracy, BioMed, Bleeding disorders, stakeholder news & views, clinical trials, patient-centered, efficiency, IVDR, Blood Cancer, CLL, CML, lymphoma, HARMONY, T2EVOLVE, GoCART, European Cancer, ECO, Summit, anneke brand, in memoriam, TOLERATE, EU funding, Lighting the flame, hematology, specialty, career, plasma, shortage, PDMPs, HOPE, HOPE Asia, 2022, Hybrid, Bangkok, EHA-SWG Infection in Hematology, Klimko, Jean Claude Brouet, SoHO, THD, support, earthquake, Türkiye , AGM, Minutes, Members, solidarity, Morocco, Statement, i4MDS, press release, patient care, survey

EHA launches Global Hematology Professionals’ Survey – make your voice heard

Mar 27 2023 Posted in Press releases

The Hague (Netherlands), March 27, 2023.

Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation

Mar 20 2023 Tagged advocacy news, stakeholder news & views

EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1

Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the center of the EU policy and regulatory stage.